This groundbreaking discovery suggests that the expression patterns of multiple genes, particularly TRADD2 and MAP3K7, may play a crucial role in chemotherapy resistance in peripheral T-cell lymphoma (PTCL). The gene discussed is MAP3K7; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.